14.40

1.41% 0.20

After Hours: 14.40

Surgery Partners Inc (SGRY)

Overview News Price History Option Chain Financials Discussions Forecast

Surgery Partners Inc stock is traded at $14.40, with a volume of 1.76M. It is up +1.41% in the last 24 hours and up +2.49% over the past month. Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities, which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earn revenues from contracts with patients in which the performance obligations are to provide health care services.

Previous Close:

$14.20

Open:

$14.22

24h Volume:

1.76M

Relative Volume:

0.83

Market Cap:

$1.89B

Revenue:

$3.34B

Net Income/Loss:

$97.10M

P/E Ratio:

-24.20

EPS:

-0.595

Net Cash Flow:

$208.00M

1W Performance:

+8.68%

1M Performance:

+2.49%

6M Performance:

+19.50%

1Y Performance:

-33.30%

1-Day Range:

$14.19

$14.67

1-Week Range:

$13.09

$15.90

52-Week Range:

$11.41

$23.44

Surgery Partners Inc Stock (SGRY) Company Profile

Name

Surgery Partners Inc

Sector

Healthcare (1067)

Industry

Medical Care Facilities (49)

Phone

615-234-5900

Address

340 SEVEN SPRINGS WAY, BRENTWOOD, TN

Employee

16,000

Twitter

@surgerypartners

Next Earnings Date

2026-11-09

Latest SEC Filings

SGRY's Discussions on Twitter

Compare SGRY vs HCA, THC, EHC, FMS, DVA

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SGRY Surgery Partners Inc	14.40	1.89B	3.34B	97.10M	208.00M	-0.595
HCA Hca Healthcare Inc	435.61	94.31B	76.39B	7.81B	7.93B	29.08
THC Tenet Healthcare Corp	259.71	20.91B	21.46B	2.65B	3.35B	19.23
EHC Encompass Health Corp	123.47	12.18B	6.07B	793.80M	464.40M	5.9914
FMS Fresenius Medical Care Ag Adr	22.69	12.08B	22.44B	1.35B	2.03B	1.9002
DVA Davita Inc	178.47	11.39B	13.84B	1.10B	1.49B	10.42

Surgery Partners Inc Stock (SGRY) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-18-25	Resumed	JP Morgan	Neutral
Jul-28-25	Resumed	BofA Securities	Buy
Dec-16-24	Initiated	BofA Securities	Buy
Oct-14-24	Initiated	UBS	Buy
Oct-11-24	Initiated	KeyBanc Capital Markets	Sector Weight
Jun-28-24	Initiated	Macquarie	Outperform
Mar-06-24	Initiated	Barclays	Equal Weight
Nov-14-23	Upgrade	TD Cowen	Market Perform → Outperform
Jun-02-23	Upgrade	BofA Securities	Neutral → Buy
May-12-23	Initiated	Mizuho	Buy
Apr-21-23	Initiated	Cantor Fitzgerald	Overweight
Nov-23-22	Reiterated	RBC Capital Mkts	Outperform
Jun-15-22	Downgrade	BofA Securities	Buy → Neutral
Jan-10-22	Resumed	Citigroup	Buy
Nov-30-21	Initiated	Barclays	Overweight
Nov-29-21	Upgrade	Stifel	Hold → Buy
Nov-01-21	Initiated	JP Morgan	Neutral
Oct-18-21	Initiated	SVB Leerink	Outperform
Sep-10-21	Initiated	Cowen	Market Perform
Jun-23-21	Resumed	Stifel	Hold
Sep-17-20	Reiterated	The Benchmark Company	Buy
Apr-27-20	Upgrade	The Benchmark Company	Hold → Buy
Mar-03-20	Downgrade	The Benchmark Company	Buy → Hold
Jan-14-20	Reiterated	The Benchmark Company	Buy
Nov-16-18	Initiated	UBS	Neutral
Sep-18-18	Upgrade	BofA/Merrill	Neutral → Buy
Jun-28-18	Upgrade	Stifel	Sell → Hold
Jan-30-18	Reiterated	The Benchmark Company	Buy
Nov-01-17	Downgrade	BofA/Merrill	Buy → Neutral
Aug-09-17	Downgrade	KeyBanc Capital Mkts	Overweight → Sector Weight
Aug-09-17	Downgrade	Raymond James	Strong Buy → Mkt Perform
Aug-09-17	Downgrade	Stifel	Hold → Sell
Apr-24-17	Reiterated	Stifel	Hold
Mar-10-17	Downgrade	Stifel	Buy → Hold
Jan-31-17	Initiated	The Benchmark Company	Buy
Jun-10-16	Initiated	KeyBanc Capital Mkts	Overweight
Mar-14-16	Reiterated	RBC Capital Mkts	Outperform
Oct-27-15	Initiated	Stifel	Buy
Oct-26-15	Initiated	RBC Capital Mkts	Outperform
Oct-26-15	Initiated	Raymond James	Strong Buy

View All

Surgery Partners Inc Stock (SGRY) Latest News

Sep 25, 2026

Wall Street Analysts See a 26.14% Upside in Surgery Partners (SGRY): Can the Stock Really Move This High? - Eastern Progress

Sep 25, 2026

Sep 24, 2026

A Look at Surgery Partners Inc (SGRY) After 7.8% Decline -- GF V - GuruFocus

Sep 24, 2026

Sep 23, 2026

Surgery Partners, 10x Genomics, QuidelOrtho, Zimmer Biomet, and Tandem Diabetes Stocks Trade Down, What You Need To Know - Yahoo Finance

Sep 23, 2026

Behavioral Patterns of SGRY and Institutional Flows - Stock Traders Daily

Sep 23, 2026

Surgery Partners (SGRY): Buy, Sell, or Hold Post Q2 Earnings? - Yahoo Finance

Sep 23, 2026

Surgery Partners: A 'Buy' After Idaho Falls Asset Divestment (NASDAQ:SGRY) - Seeking Alpha

Sep 23, 2026

Surgery Partners (SGRY) Soars 15.7%: Is Further Upside Left in the Stock? - Yahoo Finance

Sep 23, 2026

Sep 21, 2026

Surgery Partners closes $800 million deal for Idaho hospitals - The Business Journals

Sep 21, 2026

Sep 19, 2026

Surgery Partners (SGRY) Resets 2026 Outlook On Facility Removal As Valuation Questions Build - simplywall.st

Sep 19, 2026

Analysts Offer Insights on Healthcare Companies: Surgery Partners (SGRY), Envista Holdings (NVST) and Inventiva (IVA) - The Globe and Mail

Sep 19, 2026

Sep 18, 2026

SGRY Reiterated by TD Cowen -- Price Target Maintained at $19 - GuruFocus

Sep 18, 2026

BofA Securities Maintains Surgery Partners(SGRY.US) With Buy Rating, Raises Target Price to $20 - Moomoo

Sep 18, 2026

Sep 17, 2026